Location · Rochester, MN
Clinical trials in Rochester, MN
271 recruiting studies have a site in Rochester, and 115 of them accept healthy volunteers.
271 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingPhase 2
A Study of TAK-411 in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Takeda
- Location
- Rochester, MN + 11 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
Cardiac RADIoablation Versus Repeat Catheter Ablation: a Pivotal Randomized Clinical Trial Evaluating Safety and Efficacy for Patients With High-risk Refractory Ventricular Tachycardia (RADIATE-VT)
Varian, a Siemens Healthineers Company
- Location
- Rochester, MN + 10 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 1
AMX0114 in Adult Participants With Amyotrophic Lateral Sclerosis
Amylyx Pharmaceuticals Inc.
- Location
- Rochester, MN + 9 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 1/Phase 2
Anti-VEGF Gene Therapy Trial for Vestibular Schwannoma
Akouos, Inc.
- Location
- Rochester, MN + 3 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study to Assess How Effective and Safe NVD003 is for Treating Patients With Congenital Pseudarthrosis of the Tibia.
Novadip Biosciences
- Location
- Rochester, MN + 3 other US sites
- Eligibility basics
- Up to age 17
- RecruitingPhase 3
MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
Intellia Therapeutics
- Location
- Rochester, MN + 36 other US sites
- Eligibility basics
- Ages 18–90
- RecruitingPhase 1/Phase 2
Multi-center, Open-label, Single-ascending Dose Study of Safety and Tolerability of TN-201 in Adults With Symptomatic MYBPC3 Mutation-associated HCM
Tenaya Therapeutics
- Location
- Rochester, MN + 4 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
Study to Learn About the Safety of Fazirsiran and if it Can Help People With Alpha-1 Antitrypsin Liver Disease With Mild Liver Scarring (Fibrosis)
Takeda
- Location
- Rochester, MN + 19 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
Extracellular Vesicle Treatment for Acute Respiratory Distress Syndrome (ARDS) (EXTINGUISH ARDS)
Direct Biologics, LLC
- Location
- Rochester, MN + 30 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 4
CraniSeal Post Approval Study
Pramand LLC
- Location
- Rochester, MN + 6 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study
VenoStent
- Location
- Rochester, MN + 27 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
REFLECT Scoliosis System Post Approval Study
Globus Medical Inc
- Location
- Rochester, MN
- Eligibility basics
- Any age listed
- RecruitingPhase 2
A Long-term Study of the Safety and Effectiveness of RAP-219 in Adults With Focal Onset Seizures
Rapport Therapeutics Inc.
- Location
- Rochester, MN + 6 other US sites
- Eligibility basics
- Ages 18–70
- RecruitingPhase 2
Safety & Efficacy of DCR-PHXC in Patients With PH1 and ESRD
Dicerna Pharmaceuticals, Inc., a Novo Nordisk company
- Location
- Rochester, MN
- Eligibility basics
- Any age listed
- RecruitingPhase 1/Phase 2
Treatment of Moderate to Severe Refractory Crohn's Disease
Tr1X, Inc.
- Location
- Rochester, MN + 12 other US sites
- Eligibility basics
- Ages 18–65
- Recruiting
Melodi Matrix™ in Breast Reconstruction
Melodi Health, Inc.
- Location
- Rochester, MN + 9 other US sites
- Eligibility basics
- Ages 22+ · Women only
- Recruiting
A Double Blind, Randomized Controlled Study, Evaluating the Safety and Efficacy of RD2 Ver.02 For the Management of Anal Fistulas
RedDress Ltd.
- Location
- Rochester, MN + 7 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension System
Aria CV, Inc
- Location
- Rochester, MN + 8 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 1
Single and Multiple Dose Escalation of PHIN-214 in Child-Pugh A and B Liver Cirrhotics
PharmaIN
- Location
- Rochester, MN + 8 other US sites
- Eligibility basics
- Ages 18–75
- Recruiting
The PeriCut Catheter System Early Feasibility Study (REIMAGINE-HFpEF)
Heart Failure Solutions, Inc.
- Location
- Rochester, MN
- Eligibility basics
- Ages 30+
- Recruiting
Innoventric Trillium™ Stent Graft Early Feasibility Study (EFS)
Innoventric LTD
- Location
- Rochester, MN + 8 other US sites
- Eligibility basics
- Ages 18–85
- RecruitingPhase 1
Open-label, Dose Escalation Study of Safety and Preliminary Efficacy of TN-401 in Adults With PKP2 Mutation-associated ARVC
Tenaya Therapeutics
- Location
- Rochester, MN + 6 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingPhase 2
A Study of NST-6179 in Subjects With Intestinal Failure-Associated Liver Disease (IFALD).
NorthSea Therapeutics B.V.
- Location
- Rochester, MN + 11 other US sites
- Eligibility basics
- Ages 16+
- Recruiting
PARTNER 3 Trial - Aortic Valve-in-Valve
Edwards Lifesciences
- Location
- Rochester, MN + 28 other US sites
- Eligibility basics
- Any age listed